| Primary |
| Hypercholesterolaemia |
71.4% |
| Blood Cholesterol Increased |
28.6% |
|
| Rhabdomyolysis |
50.0% |
| Vision Blurred |
50.0% |
|
| Secondary |
| Hypercholesterolaemia |
20.7% |
| Product Used For Unknown Indication |
14.7% |
| Blood Cholesterol Increased |
11.8% |
| Cerebrovascular Accident |
9.2% |
| Hypertension |
7.5% |
| Lipid Metabolism Disorder |
6.5% |
| Hyperlipidaemia |
5.3% |
| Abdominal Pain Upper |
2.4% |
| Drug Use For Unknown Indication |
2.4% |
| Myalgia |
2.4% |
| Renal Cancer Metastatic |
2.2% |
| Adjustment Disorder |
1.9% |
| Dyslipidaemia |
1.9% |
| Hypertriglyceridaemia |
1.9% |
| Muscle Spasms |
1.9% |
| Biliary Cirrhosis Primary |
1.4% |
| Blood Triglycerides |
1.4% |
| Cramps |
1.4% |
| Muscle Pain |
1.4% |
| Stomach Pain |
1.4% |
|
| Rhabdomyolysis |
26.0% |
| Vision Blurred |
13.5% |
| Weight Increased |
7.3% |
| Musculoskeletal Discomfort |
6.3% |
| Psoriasis |
6.3% |
| Thrombosis |
6.3% |
| Ventricular Tachycardia |
4.2% |
| Muscular Weakness |
3.1% |
| Renal Failure Acute |
3.1% |
| Thrombophlebitis |
3.1% |
| Blood Alkaline Phosphatase Increased |
2.1% |
| Hypertension |
2.1% |
| Liver Function Test Abnormal |
2.1% |
| Musculoskeletal Disorder |
2.1% |
| Myalgia |
2.1% |
| Near Drowning |
2.1% |
| Nervous System Disorder |
2.1% |
| Pain In Extremity |
2.1% |
| Pancreatitis Acute |
2.1% |
| Skin Disorder |
2.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
16.5% |
| Drug Use For Unknown Indication |
15.3% |
| Hiv Infection |
11.8% |
| Hypertension |
11.3% |
| Hyperlipidaemia |
7.7% |
| Diabetes Mellitus |
5.2% |
| Prophylaxis |
5.2% |
| Rheumatoid Arthritis |
5.1% |
| Type 2 Diabetes Mellitus |
2.6% |
| Osteoporosis |
2.3% |
| Hypertriglyceridaemia |
2.2% |
| Adverse Event |
2.2% |
| Dyslipidaemia |
2.1% |
| Schizophrenia |
1.9% |
| Depression |
1.6% |
| Insomnia |
1.6% |
| Hypercholesterolaemia |
1.6% |
| Lipid Metabolism Disorder |
1.5% |
| Hepatitis C |
1.3% |
| Non-small Cell Lung Cancer |
1.1% |
|
| Vomiting |
9.1% |
| Liver Disorder |
8.5% |
| Urinary Retention |
7.4% |
| Thrombocytopenia |
6.3% |
| Malaise |
5.7% |
| Syncope |
5.7% |
| Deep Vein Thrombosis |
5.1% |
| Pyrexia |
5.1% |
| Rash |
5.1% |
| Temporal Arteritis |
4.5% |
| Toxic Skin Eruption |
4.5% |
| Anaemia |
4.0% |
| Death |
4.0% |
| Metastases To Liver |
4.0% |
| Weight Decreased |
4.0% |
| Haemolytic Anaemia |
3.4% |
| Hyponatraemia |
3.4% |
| Interstitial Lung Disease |
3.4% |
| Myalgia |
3.4% |
| Oedema Peripheral |
3.4% |
|
| Interacting |
| Drug Use For Unknown Indication |
70.0% |
| Product Used For Unknown Indication |
20.0% |
| Computerised Tomogram |
10.0% |
|
| Rhabdomyolysis |
50.0% |
| Myopathy |
16.7% |
| Pain In Extremity |
16.7% |
| Thrombocytopenia |
16.7% |
|
